The present invention relates to low concentration synergistic Xenon-Argon gas mixtures argon for use in a method for preventing and/or treating ischemic insults, wherein —the volume proportion of xenon is between 5 and 20%; —the volume proportion of argon is between 5 and 20%; and —the pharmaceutical composition further comprises a gas complement to reach 100% volume proportion; —the method includes comprises restoration of blood flow and the gas mixture is administered to the patient before, during, or after blood flow restoration.

The present disclosure describes a bi-valve for use with a flowmeter or other source of oxygen or other medical gas, that allows a medical practitioner to easily and quickly switch from delivering oxygen or other gas from the flowmeter or other gas source to a given mask or other device, to another mask or other device. This is accomplished far faster and easier than is done under current practice. Current practice results in the patient being off oxygen or other gas for a short, but very significant period of time, which poses a serious risk of desaturation in the patient. The bi-valve may include a casing, an inlet, and two outlets, with a knob for selecting which output the oxygen or other gas is to be delivered to. The device may be a very simple ball valve device, with the only moving parts being the knob and the ball.

Systems, methods and apparatuses for vaporizing all or substantially all plant matter, liquid and/or other material to be vaporized are disclosed. Embodiments of the invention comprise a vaporization chamber sealed except for at least two conduits, heating element, a first conduit coupled to a source of fully or almost fully non-oxygenated gas, a heating element capable of heating the vaporization chamber to a temperature above a combustion temperature, a second conduit configured to transport vaporization gases and vaporized elements out of the vaporization chamber and at least one valve positioned in the second conduit preventing the flow of atmospheric air into the vaporization chamber. In some instances, the first gas substantially clears the vaporization chamber of atmospheric air prior to reaching combustion temperature. A second gas containing oxygen may be intermixed with the vaporization gases and vaporized elements proximal to the combustion chamber.

A sensing arrangement for a medical device includes a housing having a rigid portion and a flexible portion, a collar of the flexible portion attached to an exterior of the rigid portion such that a stem of the rigid portion extends into an interior of the flexible portion. A sensing element is positioned at least partially within a passageway of the rigid portion, with at least one wire extending from the sensing element through the passageway and into the interior of the flexible portion. Front and rear flanges protrude from the flexible portion and are adapted to allow the sensing arrangement to be attached into an aperture in a wall of the medical device. The stem of the rigid portion may be positioned between the collar and front flanges of the flexible portion, such that the stem does not extend through the aperture of the wall of the medical device. There are also provided a seal, a removable component, a medical device and a system.

Components for a respiratory treatment apparatus that is capable of providing a humidified respiratory treatment permit a reduction in condensation in a patient interface and/or its gas delivery tubing. In some embodiments, a rainout valve that may be an integrated component of a humidifier output aperture, or coupled thereto, may reduce condensation with a vapor barrier operable to selectively block and permit humidified gas transfer from the humidifier. For example, the barrier may be operable to open in response to a flow of pressurized breathable gas that may be generated by a flow generator of the respiratory treatment apparatus. In the absence of such a generation of pressurized flow, the barrier may prevent a transfer of the humidified gas such as into a conduit for a patient interface by retracting to a closed position. Example vapor barriers may include a resilient membrane, cover, bellows, flap, shutter or other suitable valve.

Various control methods can indirectly determine incorrect connections between components in a respiratory therapy system. For example, incorrect connections can occur between a patient interface, a humidifier and/or a gases source. The methods can indirectly detect if reverse flow conditions or other error conditions exist. A reverse flow condition can occur when gases flows in a direction different from an intended direction of flow. The methods can be implemented at the humidifier side, at the gases source side, or both.

An apparatus to maintain an environment over an anterior surface of a patient eye can include an enclosure sized and shaped to be seated about the patient eye to form a cavity within the enclosure. The enclosure can be configured to contain a fluid other than ambient air in contact with the patient eye. The apparatus can include a fluid regulator in communication with the enclosure, where the fluid regulator can be configured to regulate the composition of the fluid contained within the enclosure.

An apparatus to maintain an environment over an anterior surface of a patient eye can include an enclosure sized and shaped to be seated about the patient eye to form a cavity within the enclosure. The enclosure can be configured to contain a fluid other than ambient air in contact with the patient eye. The apparatus can include a fluid regulator in communication with the enclosure, where the fluid regulator can be configured to regulate the composition of the fluid contained within the enclosure.

Disclosed is a method of treating microbial infections and their associated complications in humans. The method includes administering to a patient, a composition of dextrose and ethanol. The composition can be administered in the form of an infusion. For patients suffering from respiratory complications, the disclosed method also provides for enhancing oxygen uptake by lungs and reducing oxygen resistance through the administration of air having helium gas and excited oxygen atoms.

Disclosed is a method of treating microbial infections and their associated complications in humans. The method includes administering to a patient, a composition of dextrose and ethanol. The composition can be administered in the form of an infusion. For patients suffering from respiratory complications, the disclosed method also provides for enhancing oxygen uptake by lungs and reducing oxygen resistance through the administration of air having helium gas and excited oxygen atoms.